Abstract
BackgroundAccumulating evidence indicates that some non-absorbed food additives, including emulsifiers carboxymethylcellulose (CMC) and polysorbate 80 (P80), can negatively impact intestinal microbiota, leading to microbiota encroachment, chronic low-grade intestinal inflammation and, subsequently, promotion of metabolic dysregulations. Detrimental impacts of emulsifier consumption on gut microbiota include depletion of the health-associated mucus-fortifying bacteria,Akkermansia muciniphila.ObjectiveInvestigate, in mice, the potential of administration of exogenousA. muciniphilaas a means to protect against detrimental impacts of emulsifiers.ResultsDaily oral administration ofA. muciniphilaprevented phenotypic consequences of consumption of both CMC and P80, including hyperphagia, weight gain and dysglycaemia.A. muciniphilaadministration also counteracted the low-grade intestinal inflammation-induced CMC and P80. Furthermore,A. muciniphilasupplementation prevented the proximal impacts of CMC and P80 on gut microbiota that are thought to drive low-grade chronic inflammation and metabolic dysregulations. Specifically,A. muciniphilaprevented alterations in species composition and encroachment of gut microbiota that were otherwise induced by CMC and P80. Remarkably, we finally report that CMC and P80 altered the colonic transcriptome, whileA. muciniphilalargely protected against these alterations.ConclusionDaily administration ofA. muciniphilaprotects against the detrimental impact of emulsifiers on both the microbiota and host. These results support the notion that use ofA. muciniphilaas a probiotic can help maintain intestinal and metabolic health amidst the broad array of modern stresses that can promote chronic inflammatory diseases.
Funder
Kenneth Rainin Foundation
H2020 European Research Council
IdEx Université de Paris
Agence Nationale de la Recherche
INSERM
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献